Cornea disorders encompass a wide range of conditions that damage, distort, or cloud the thin, transparent tissue at the front of the eye. Because the cornea handles roughly two-thirds of the eye’s focusing power and serves as the primary barrier between the outside world and the delicate structures behind it, even small disruptions can cause blurred vision, pain, or light sensitivity. Some cornea disorders are inherited, some arise from infections or injuries, and others develop slowly over decades with no obvious trigger. What ties them together is that they all threaten the cornea’s two defining features: clarity and shape.
What Makes the Cornea So Transparent, and So Fragile
The cornea is made up of five recognized layers, with a sixth layer identified more recently through advances in surgical techniques. The three cellular layers are the epithelium on the outside, the stroma in the middle, and the endothelium on the inner surface. Sandwiched between them are two thin acellular membranes: Bowman’s membrane and Descemet’s membrane. The newly identified pre-Descemet layer (sometimes called Dua’s layer) sits between the stroma and Descemet’s membrane.1PubMed Central. Clinical anatomy: cornea and ocular surface
Transparency depends on a remarkably precise arrangement of collagen fibers in the stroma. These fibers are spaced at intervals smaller than half the wavelength of visible light, which minimizes scattering and allows light to pass through cleanly. The stroma alone accounts for about 90 percent of the cornea’s thickness, and its hydration level has to be kept within a narrow range. Too much water and the tissue swells and turns hazy; too little and it warps. The endothelium constantly pumps fluid out to maintain this balance.2PubMed Central. Clinical anatomy: cornea and ocular surface
The cornea is also one of the very few tissues in the body that has no blood vessels running through it. This “angiogenic privilege” is actively maintained: the cornea produces anti-angiogenic molecules that counterbalance pro-angiogenic signals, even during wound healing.3PubMed Central. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing When this balance tips, blood vessels invade the cornea, and clarity drops. Similarly, the cornea has one of the densest nerve networks of any tissue in the body, making it exquisitely sensitive to touch and injury, but also vulnerable to nerve-related disorders when those nerves are damaged.
Keratoconus
Keratoconus is a progressive condition in which the cornea gradually thins and bulges outward into a cone-like shape. It usually starts during the teenage years or early twenties and affects both eyes, though often unevenly.4PubMed Central. Corneal collagen crosslinking in keratoconus and other eye disease The distorted shape causes increasingly irregular astigmatism and blurred vision that glasses alone cannot fully correct. In mild to moderate cases, rigid or specialty contact lenses can compensate for the irregular surface. When the disease progresses far enough, a corneal transplant becomes necessary.
The most significant treatment advance in the past two decades has been corneal collagen cross-linking, which uses riboflavin (vitamin B2) drops and ultraviolet-A light to strengthen the bonds between collagen fibers, making the cornea stiffer and more resistant to further bulging.5PubMed. Current status of corneal collagen cross-linking for keratoconus: a review Cross-linking does not reverse existing distortion, but it can halt progression. This makes early detection critical, because the sooner the cornea is stabilized, the less visual damage accumulates.
Eye rubbing is increasingly recognized as a significant modifiable risk factor. Mechanical trauma from habitual rubbing weakens collagen bonds and accelerates thinning. People with allergies, who tend to rub their eyes frequently, show up disproportionately among keratoconus patients. Other risk factors include young age and a family history of the condition.6PubMed Central. Risk Profiles of Ectasia after Keratorefractive Surgery
Infectious Keratitis
Infections of the cornea, collectively called keratitis, rank among the most urgent corneal emergencies because they can permanently scar the tissue within days. Bacteria, fungi, viruses, and parasites can all be responsible, and the treatment differs dramatically depending on the cause. The trouble is that even experienced clinicians correctly distinguish bacterial from fungal keratitis only about two-thirds of the time based on appearance alone.7PubMed Central. The Clinical Differentiation of Bacterial and Fungal Keratitis: A Photographic Survey Features like feathery or irregular borders tend to point toward fungal infection, while a wreath-shaped infiltrate or an epithelial plaque favors a bacterial cause. Lab cultures and scrapings remain essential for confirming the organism.
The distinction matters for prognosis. Fungal keratitis heals far more slowly than bacterial keratitis, with a median time for the surface to close over of about 15 days compared with roughly a week for bacterial infections. Fungal cases also carry a much higher perforation rate: about 16 percent versus around 3 percent in bacterial keratitis.8JAMA Ophthalmology. Differences in Clinical Outcomes in Keratitis Due to Fungus and Bacteria Treatment for bacterial keratitis generally involves intensive fortified antibiotic drops, while fungal keratitis requires antifungal agents that penetrate the cornea less effectively and work more slowly.
Acanthamoeba Keratitis
Acanthamoeba keratitis deserves special attention because it is both preventable and devastatingly painful when it occurs. This parasitic infection is overwhelmingly linked to contact lens wear combined with water exposure. A multistate case-control study identified several specific risk factors: rinsing or storing lenses in tap water, topping off old solution in the lens case rather than replacing it, and rinsing the case itself with tap water.9Eye & Contact Lens. Risk Factors for Acanthamoeba Keratitis—A Multistate Case–Control Study, 2008–2011 People who had worn lenses for five years or fewer were also at higher risk, possibly because they had not yet internalized good hygiene habits.
The single biggest preventive message for contact lens wearers is straightforward: keep lenses away from water. That means no swimming or showering while wearing them, no rinsing them under the tap, and no topping off solution. Fresh solution every time, and replacing the case regularly, go a long way toward reducing exposure.10PubMed. Strategies for the prevention of contact lens-related Acanthamoeba keratitis: a review Once established, Acanthamoeba keratitis is notoriously difficult to treat and can require months of intensive antiseptic drops.
Fuchs Endothelial Corneal Dystrophy
While infections strike suddenly, corneal dystrophies develop gradually, often over decades. The most common of these is Fuchs endothelial corneal dystrophy, in which the innermost endothelial cells progressively die off. Because the endothelium’s pump function is what keeps the cornea from swelling, the loss of these cells eventually allows fluid to accumulate in the stroma. Descemet’s membrane thickens and develops wart-like bumps called guttae. When enough endothelial cells are lost, the cornea swells visibly and vision becomes cloudy, typically worse in the morning (when overnight eyelid closure reduces evaporation and worsens edema) and improving somewhat during the day.11Elsevier. Fuchs Endothelial Corneal Dystrophy
The treatment landscape for Fuchs has shifted substantially. A decade ago, full-thickness corneal transplants were standard. Today, endothelial keratoplasty procedures, which replace only the innermost layer rather than the entire cornea, have become the preferred approach. Recovery is faster, the risk of rejection is lower, and visual outcomes tend to be better because the cornea’s front surface is left undisturbed. In mild to moderate cases, some patients manage with hypertonic saline drops that draw fluid out of the cornea, delaying or avoiding surgery.
Neurotrophic Keratitis and Corneal Nerve Damage
The cornea’s dense nerve supply does more than register pain. Corneal nerves release substances that keep the surface cells healthy and promote healing when the epithelium is damaged. When those nerves are injured or diseased, the result is neurotrophic keratitis: the cornea loses sensation, the surface breaks down spontaneously, and wounds that would normally heal in a day or two simply will not close.12PubMed Central. Diagnosis and management of neurotrophic keratitis Causes include herpes simplex and herpes zoster infections of the eye, diabetes, certain surgeries (including LASIK), tumors pressing on the trigeminal nerve, and stroke.
A breakthrough treatment arrived with recombinant nerve growth factor (cenegermin), the first medication specifically approved for neurotrophic keratitis. In clinical studies, persistent epithelial defects healed completely within eight weeks in all treated patients, accompanied by measurable regrowth of corneal nerves.13PubMed. In Vivo Evaluation of Corneal Nerves and Epithelial Healing After Treatment With Recombinant Nerve Growth Factor for Neurotrophic Keratopathy Longer-term follow-up confirmed that nerve regrowth continued progressively, starting from the corneal periphery and branching inward, with effects persisting through at least eight months of monitoring.14PubMed Central. Eight months follow-up of corneal nerves and sensitivity after treatment with cenegermin for neurotrophic keratopathy Before cenegermin, treatment options were limited to protective measures like bandage contact lenses, tarsorrhaphy (partially stitching the eyelids shut), and amniotic membrane grafts.
Limbal Stem Cell Deficiency
At the border between the cornea and the white of the eye sits a ring of tissue called the limbus, which houses the stem cells responsible for continuously regenerating the corneal epithelium. When these stem cells are destroyed by chemical burns, thermal injuries, chronic inflammation, or certain inherited conditions, the conjunctival tissue from the white of the eye migrates over the cornea, bringing blood vessels and opaque scar tissue with it. Manifestations range from chronic dryness and redness to corneal ulceration and severe vision loss.15PubMed Central. The Multifold Etiologies of Limbal Stem Cell Deficiency: A Comprehensive Review on the Etiologies and Additional Treatment Options for Limbal Stem Cell Deficiency
The standard treatment involves transplanting healthy limbal stem cells, either from the patient’s unaffected eye or from a donor. A phase I/II clinical trial of cultivated autologous limbal epithelial cell (CALEC) transplantation, using the first xenobiotic-free, serum-free, antibiotic-free manufacturing process developed in the United States, showed that roughly 92 percent of grafts achieved complete or partial success at 18 months.16PubMed Central. Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal stem cell deficiency Research is also exploring 3D-printed bilayer limbal implants that combine epithelial cells with stromal stem cells to rebuild both the surface and the niche that supports stem cell survival, potentially improving long-term results over cell transplantation alone.17PubMed. 3D printed biomimetic bilayer limbal implants for regeneration of the corneal structure in limbal stem cell deficiency
Pterygium and UV Damage
A pterygium is a wedge-shaped growth of fleshy tissue that extends from the conjunctiva onto the cornea, usually on the nasal side. While technically a growth on the ocular surface rather than a primary corneal disease, it directly affects the cornea when it encroaches over the pupil or distorts the corneal shape enough to cause astigmatism. Ultraviolet radiation is the dominant environmental cause. A survey of over 100,000 people in rural Australia found a strong positive correlation between regional UV levels and pterygium prevalence.18PubMed Central. Pterygium and ultraviolet radiation: a positive correlation UV exposure alters limbal stem cells and fibroblasts and triggers pro-inflammatory cytokines and growth factors that drive the tissue forward.19PubMed. The role of ultraviolet radiation in the pathogenesis of pterygia
Pterygia are most common in people who spend significant time outdoors, particularly near the equator or around reflective surfaces like water and sand. Wrap-around sunglasses that block lateral UV exposure are the best preventive measure. Surgical removal is straightforward, but recurrence is a persistent problem unless the surgeon grafts a piece of conjunctival tissue over the excision site to reduce the chance of regrowth.
When Blood Vessels Invade the Cornea
Corneal neovascularization occurs when the cornea’s natural defense against blood vessels is overwhelmed by pro-angiogenic signals. The result is visible vessels growing into what should be transparent tissue, scattering light and reducing clarity. Common triggers include prolonged contact lens wear (especially with lenses that starve the cornea of oxygen), chronic infections, herpes keratitis, chemical injuries, and prior surgery.20PubMed Central. Corneal neovascularization: updates on pathophysiology, investigations & management
No treatment currently cures corneal neovascularization completely. Corticosteroid drops are the first-line therapy because they reduce inflammation and slow new vessel growth, but they have limited ability to shrink mature vessels and carry risks with long-term use, including elevated eye pressure and cataract formation. Anti-VEGF injections, borrowed from retinal disease treatment, show promise for newer vessels, and laser photocoagulation can target individual vessels. The field is actively exploring subconjunctival injections and combination approaches, but outcomes remain variable.21PubMed Central. Management of corneal neovascularization: Current and emerging therapeutic approaches
Corneal Problems After Refractive Surgery
Post-LASIK ectasia, in which the cornea progressively thins and bulges after laser vision correction, is the complication refractive surgery patients fear most. Risk factors identified through large case-control analyses include abnormal preoperative topography (the strongest predictor), thin corneas, high myopia, younger age, and a low residual stromal bed thickness after the procedure.22PubMed. Risk assessment for ectasia after corneal refractive surgery A metric called “percent tissue altered” has emerged as a useful screening tool; values above 40 percent raise concern.23PubMed Central. Risk Profiles of Ectasia after Keratorefractive Surgery
Interestingly, a systematic review has argued that the boundary between “iatrogenic ectasia” caused by the surgery and “unmasked keratoconus” that was subclinically present beforehand may be blurrier than traditionally thought. Some patients diagnosed with post-surgical ectasia likely had early keratoconus that was not detected on preoperative screening, and the surgical thinning simply accelerated what would have eventually happened on its own.24PubMed Central. Ectasia After Corneal Refractive Surgery: A Systematic Review This understanding has pushed preoperative screening to incorporate more sophisticated corneal tomography, which maps both the front and back surfaces in three dimensions, rather than relying on topography of the front surface alone.25PubMed. Applications of corneal topography and tomography: a review
Corneal Transplantation and Artificial Corneas
Corneal transplantation has a long history. Animal-to-animal experiments began in 1818, and the first successful human corneal transplant was performed in 1905. Today, it is the most common tissue transplant in the world, but demand vastly outstrips supply. A global survey covering 91 percent of the world’s population found roughly 12.7 million people on waiting lists for a corneal transplant, with the most severe shortages in India and China. Over half the world’s population had essentially no access to the procedure.26JAMA Ophthalmology. Global Survey of Corneal Transplantation and Eye Banking
For patients who have failed one or more donor corneal transplants, or who have conditions that make transplant rejection almost certain, artificial corneas (keratoprostheses) offer an alternative. The Boston Type I keratoprosthesis is the most widely used. Across published studies, vision improved to at least 20/200 in roughly half to nearly 90 percent of eyes, depending on the case series, and retention rates ranged from 65 to 100 percent.27Ophthalmology. Ophthalmic Technology Assessment: The Boston Type I Keratoprosthesis Long-term follow-up showed that about 58 to 82 percent of eyes maintained vision of 20/200 or better between one and eight years after surgery.28Cornea. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis The most frequent complication was retroprosthetic membrane formation, occurring in roughly half of eyes, which typically requires a laser procedure to clear. Elevated eye pressure and infection are ongoing risks that require lifelong monitoring.
When used as the first procedure rather than after a failed conventional transplant, the keratoprosthesis appeared to deliver more durable vision: the probability of maintaining good postoperative vision at five years was about 79 percent in primary cases versus 49 percent in secondary cases.29PLoS ONE. Five year outcomes of Boston type I keratoprosthesis as primary versus secondary penetrating corneal procedure in a matched case control study
When the Cornea Signals a Whole-Body Problem
The cornea can serve as an early warning system for systemic disease. Autoimmune conditions like rheumatoid arthritis and lupus can cause peripheral corneal melting or severe dry eye. Diabetes is linked to delayed corneal wound healing and recurrent erosions. Wilson disease deposits copper in the cornea as a visible Kayser-Fleischer ring. Certain metabolic storage disorders cause recognizable corneal opacities in childhood. In some cases, a routine eye exam identifies corneal changes before the systemic diagnosis is made.30PubMed Central. Systemic diseases and the cornea
This connection runs both ways. Medications used for systemic conditions, including amiodarone for heart rhythm disorders and hydroxychloroquine for autoimmune disease, can deposit in the cornea and affect vision. Being aware of these links helps both patients and clinicians make earlier diagnoses and avoid attributing corneal symptoms to a local cause when the real issue is systemic.
Corneal Disorders in Children
Pediatric corneal problems present unique challenges because a cloudy cornea in infancy can block visual development and cause permanent amblyopia (lazy eye) if not treated quickly. Peters anomaly is a rare congenital condition in which the cornea is opaque at birth due to defects in Descemet’s membrane and abnormal adhesions between the iris or lens and the cornea.31PubMed Central. Peters anomaly: An overview Traditional treatment required a full-thickness corneal transplant, which carries a high failure rate in children because of vigorous immune responses and the difficulty of postoperative care in infants.
A more recent surgical innovation, selective endothelialectomy, strips away the diseased endothelial layer and allows the child’s own endothelium to regenerate and clear the opacity over time, avoiding the need for a donor cornea entirely. In a series of 34 eyes, about 85 percent maintained a successful outcome at roughly one year, and 97 percent showed functional visual improvement. Only disease severity (specifically, more advanced Type 2 Peters anomaly) predicted failure.32PubMed Central. Selective Endothelialectomy in Peters Anomaly: A Novel Surgical Technique and Its Clinical Outcomes in Children For families, this approach represents a major shift: fewer surgical complications, no dependence on donor tissue, and no lifelong anti-rejection medications.
The Ocular Surface Microbiome
Research over the past decade has revealed that the eye’s surface, long assumed to be nearly sterile, harbors a community of microorganisms that actively contributes to corneal health. This ocular surface microbiome helps defend against pathogenic colonization and supports normal immune regulation. When this community is disrupted, whether by antibiotic overuse, preservatives in eye drops, or changes in the tear film, the cornea becomes more susceptible to infection.33PubMed Central. Perturbations of the ocular surface microbiome and their effect on host immune function This is a relatively young field, but the clinical implication is already clear: indiscriminate use of antibacterial eye drops, or unnecessary exposure to preservatives, may do more harm than good in situations where the cornea is not actually infected.
Gene Therapy and Drug Delivery on the Horizon
The cornea’s unique properties, being immune-privileged, avascular, and transparent, make it an appealing target for gene therapy. Researchers are exploring viral and non-viral vectors that can deliver therapeutic genes directly to corneal cells, with the goal of correcting inherited dystrophies at their genetic root rather than managing symptoms or waiting for transplantation.34PubMed Central. Corneal Regeneration Using Gene Therapy Approaches Most of this work remains preclinical, but the transparency of the cornea allows direct visual monitoring of treatment effects, which is a practical advantage for clinical trials.
A separate challenge is simply getting drugs into the cornea efficiently. Traditional eye drops are famously wasteful: the corneal epithelium’s tight junctions block most molecules, and the bioavailability of topically applied drugs is generally less than 5 percent. Nanotechnology-based delivery systems, including nanoparticles, liposomes, and hydrogel formulations, are being engineered to cross the epithelial barrier and release medication in a sustained fashion, potentially replacing the exhausting hourly drop regimens that some corneal infections demand.